Year: 2019

  • Bold ideas for the joint design of assistive technology provision

    Bold ideas for the joint design of assistive technology provision

    —

    by

    admin
    in , ,

    We would like to thank you for attending the Outpatient Partner Conference for Assistive Technology Providers on November 15, 2019. It was a very interesting conference where we developed ideas together on how we can implement better care for the patients in our network. Here are some impressions of the conference. We will keep you…

  • Study to record treatment with nusinersen in adults

    —

    by

    admin
    in , ,

    Nusinersen (Spinraza®) is approved for the treatment of 5q-associated spinal muscular atrophy (SMA). For infants and children, nusinersen can halt the progression of the disease and improve muscle function. For adults, no systematic data on treatment with nusinersen are available to date. Scientific treatment documentation is therefore necessary to improve the data situation for adults…